Paul Kluetz

@pkluetz

med onc, interested in trial design, endpoints and scientifically rigorous measurement of the patient experience- tweets and opinions are my own

Vrijeme pridruživanja: prosinac 2008.

Tweetovi

Blokirali ste korisnika/cu @pkluetz

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @pkluetz

  1. prije 10 sati

    The annual report from 2019 is up on the web. A lot of work was accomplished to advance the development of cancer therapies, and there is a lot more to do...

    Poništi
  2. proslijedio/la je Tweet
    3. velj

    African Americans have the highest death rate & shortest survival of any racial/ethnic group in the US for most cancers. Join us Feb 6 for a discussion, All Power to the Patient: Achieving Cancer Health Equity

    Poništi
  3. 1. velj

    This will be a good opportunity to hear about a host of programs has put together over the past 3 years, and how they impact various stakeholders

    Poništi
  4. proslijedio/la je Tweet
    31. sij

    wishes well as he leaves FDA for a new role. Dr. Blumenthal has had a large impact in cancer research & regulatory science and was a well-respected leader for oncology during his 14+ years of government service at FDA and NIH.

    Poništi
  5. 25. sij
    Poništi
  6. proslijedio/la je Tweet
    23. sij

    You’re invited! Thurs, Feb 6, is hosting a Black History Month panel discussion open to the public: “All Power to the Patient – Achieving Cancer Health Equity” at the FDA Great Room noon-1 pm. Register here

    Poništi
  7. proslijedio/la je Tweet

    I am delighted to announce that Dr. has returned to the FDA from the Centers for Medicare & Medicaid Services as the Deputy Commissioner for Medical and Scientific Affairs.

    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    21. sij

    Join keynote speaker and 's for our birthday recognition and public meeting on Feb. 5 at FDA or online to discuss the future of oncology drug development

    Poništi
  9. proslijedio/la je Tweet
    8. sij

    Today, released their annual Cancer Statistics report. The study found overall cancer mortality dropped 2.2% from 2016-17—the largest one-year drop ever recorded—thanks largely to improvements in certain lung cancer & melanoma treatments.

    Poništi
  10. proslijedio/la je Tweet

    As this report demonstrates, the progress we are making in is marvelous.

    Prikaži ovu nit
    Poništi
  11. proslijedio/la je Tweet
    6. sij

    Register now for the Feb. 13 - Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials. Help us work to address a major disparity in cancer care!

    Poništi
  12. proslijedio/la je Tweet

    A mounting public health tragedy in urgent need of renewed focus.

    Poništi
  13. proslijedio/la je Tweet
    6. sij

    Happy New Year and Happy 3rd Birthday to us! Join us Feb. 5 for a public meeting (in person/online) to discuss future cancer drug development - FDA Oncology Center of Excellence Update: Envisioning Oncology and Product Development for 2025

    Poništi
  14. 6. sij

    Interested in cancer therapeutic development? Celebrate the 3rd year of on February 5th at the Silver Spring, MD FDA campus. Hear updates on multiple innovative projects! Register to attend in person or remotely-

    Poništi
  15. 1. sij

    Immune toxicities... SO important ED docs ask cancer patients if they are on IO agents. Fantastic article on immune side effects featuring my friend and an ED doc from my alma mater , FYI .

    Poništi
  16. 1. sij

    For 2020, be collaborative, thoughtful and respectful as we work together on issues big and small. My son asked, "what difference can I make?" I tell him every human interaction can make a difference. Make them all count. Oh, and have fun and a sense of humor... you'll need it!

    Poništi
  17. proslijedio/la je Tweet
    31. pro 2019.

    Thanks to all for their work on these trials and reviews, and thanks most of all to the patients for participating. What will 2020 have in store---- much work still to be done. approvals to date 2/2

    Prikaži ovu nit
    Poništi
  18. 29. pro 2019.

    Wishing our ORISE fellow Jessica Roydhouse success and fulfillment as she begins her career advancing health outcomes research in Tasmania!

    Poništi
  19. proslijedio/la je Tweet
    24. pro 2019.

    All of us at the FDA wish you the happiest of holidays!

    Poništi
  20. proslijedio/la je Tweet

    I am honored to serve as the 24th Commissioner of Food and Drugs. I would like to thank for swearing me in today and for the opportunity to lead FDA. I would also like to thank my family for their support throughout this process.

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·